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SummAry – Helicobacter pylori (H. pylori) is a common problem and a significant cause of 
chronic gastric inflammation. H. pylori, ongoing gastric inflammation and its severity are the most 
critical component of precursors of gastric cancer. hypothetically, every chronic tissue injury activates 
platelets, and the mean platelet volume (mPv) reflects this action well. The potential relationship 
between H. pylori and platelet count has been shown before. however, there are few and conflicting 
papers about the relationship between mPv and H. pylori related chronic gastric inflammation and its 
severity. The study aimed to assess any potential relationship between mPv and presence of H. pylori, 
as well as the severity of chronic gastric inflammation. A total of 6890 endoscopic reports were ini-
tially evaluated, and a total of 218 dyspeptic patients having undergone upper endoscopy were in-
cluded. Of these, 118 (54.2%) were H. pylori positive and 100 (45.8%) were H. pylori negative. At least 
four gastric biopsies were obtained and evaluated according to Sydney classification. Age, gender, 
hemoglobin, mean corpuscular volume, ferritin, serum iron and C-reactive protein, as well as endo-
scopic findings were also recorded. A p<0.05 was accepted as significant. The mPv and platelet count 
did not differ between H. pylori positive and H. pylori negative groups of patients (p>0.05). There were 
no differences and correlation between mPv and gastric inflammation severity according to Sydney 
classification (p>0.05). when stratifying mPv as <9.15 fl and >9.15 fl, there was no difference be-
tween H. pylori positive and H. pylori negative groups either (p>0.05). In this study, we found no rela-
tionship between mPv and presence of H. pylori or severity of gastric inflammation. Although there 
are still conflicting publications on this issue, in our opinion and according to the results of this study, 
mPv is not a suitable marker for evaluation of gastric inflammation severity, being H. pylori either 
positive or negative.
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Introduction
Helicobacter pylori (H. pylori) infection and related 
clinical conditions such as chronic gastric inflamma-
tion, gastric cancer, and immune thrombocytopenia are 
still growing clinical problems all over the world be-
cause of some well-known difficulties in their treat-
ment, diagnosis, and management1-4. moreover, it may 
not be possible to be recognized by patient or clinicians 
unless presented with a noisy clinical picture as peptic 
ulcer bleeding because it often leads to slow chronic 
infection without manifesting itself5. It is possible to 
diagnose H. pylori infection by noninvasive tests, as rec-
ommended by well-known guidelines6. however, the 
degree of chronic gastric inflammation that is com-
monly evaluated by Sydney classification and the con-
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ditions that increase susceptibility to stomach cancer 
can almost only be understood by upper endoscopic 
biopsies, not yet with noninvasive tests6. nevertheless, 
even nowadays, the possibility of upper endoscopy is 
still not available everywhere and is not suitable for ev-
ery patient, while histologic examinations of endoscop-
ic biopsies are expensive and time-consuming7. Conse-
quently, a new, simple, reliable and straightforward in-
dicator of chronic inflammation of the stomach such as 
a blood marker is needed to overcome such difficulties8.
It is well-known that acute or chronic inflamma-
tion occurring in any part of human tissues activates 
platelets via some specific cytokines, chemokines and 
immune mediators stimulated by various cells8. The 
mean platelet volume (mPv) is a part unit of com-
plete blood count analysis that represents mainly 
platelet induction and aggravation, and that can easily 
be obtained in daily routine. It has recently been stud-
ied as an inflammatory marker, a disease severity index 
and a predictor of prognosis in a variety of acquired 
diseases including localized psoriasis, rheumatoid ar-
thritis, cardiovascular diseases, stroke, graves’ disease 
and intrahepatic cholestasis9-13. Because of these re-
markable studies, it is claimed that mPv can be a 
promising and potential blood marker of inflamma-
tion. however, although serum mPv is found to be 
statistically different in control groups in most of the 
clinical trials, some results of the studies, particularly 
those investigating local inflammations such as graves’ 
disease, psoriasis and rheumatoid arthritis, are con-
flicting and unsatisfactory13-15.
Chronic gastric inflammation is an example of lo-
cal chronic inflammation. H. pylori is one of the most 
important reasons for this. hypothetically, every 
chronic tissue injury activates platelets, and mPv re-
flects this action well. The potential relationship be-
tween H. pylori and platelet count has been shown 
before. however, there are few and conflicting papers 
about the relationship between mPv and H. pylori re-
lated chronic gastric inflammation and its severity. 
There are only two studies in the field, and confusing 
results are presented as well. topal et al.9 found that no 
statistically significant difference was obtained and 
there was no correlation and relationship between 
mPv and H. pylori intensity or gastric inflammation 
severity, whereas umit and Ümit16 report that the 
mean platelet count was lower in H. pylori positive pa-
tients than in H. pylori negative patients, whereas the 
mean mPv was higher in H. pylori positive group than 
in H. pylori negative group.
In this study, we aimed to evaluate the relationship 
between the mean mPv and gastric inflammation se-
verity, being H. pylori positive or negative. with this 
study, we hope to make an important contribution to 
the literature by clarifying the topic that has been pre-
sented with controversial results so far.
Material and Method
This study was conducted at the gastroenterology 
department, Zonguldak Bülent ecevit university 
medical faculty, a tertiary reference center for all en-
doscopic procedures. A total of 6890 endoscopic re-
ports and case files from January 2013 to June 2017 
were reviewed meticulously. The main criteria for in-
clusion in the study were as follows: dyspeptic patients 
aged 18-85 who had no cancer history and gastric sur-
gery in the past; patients with upper gastrointestinal 
endoscopy and at least four biopsies taken from the 
antrum and corpus or small curvature of stomach; pa-
tients with gastric biopsy specimens stained with he-
matoxylin-eosin and assessed in accordance with Syd-
ney classification; and patients that had complete 
blood count within the normal range before upper 
endoscopy and standard ferritin, iron, and C-reactive 
protein (CrP) levels. The main exclusion criteria were 
as follows: patients with gastric or colon dysplasia or 
polyps and any malignancy; patients with acute phase 
responses such as high level of CrP and ferritin and 
leukocytosis; patients with any chronic disease such as 
chronic hepatitis B or C, cirrhosis, rheumatologic dis-
eases; patients with any hematologic disease; patients 
with malabsorption syndrome; and patients using spe-
cial medication that could change platelet count. All 
laboratory blood tests were accepted if they were taken 
before upper endoscopy by international guidelines. 
histopathological reports were accepted if the investi-
gation was made according to Sydney classification. H. 
pylori infection and other parameters were recorded as 
the degree of intensification and severity as none, mild 
(+), moderate (++) and severe (+++). This study was 
conducted in accordance with the International hel-
sinki declaration. The local ethics committee approved 
this work (code 2017-07-13). A written informed 
consent was obtained from all patients having partici-
pated in the study.
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Statistical analysis
On statistical analysis, the windows compatible 
SPSS 18 (Chicago, Illinois, uSA) program was used. 
first, it was searched whether all data distributions 
were normal or not with at least three tests including 
Kolmogorov Smirnov test; then appropriate statistical 
methods were selected. normally distributed data were 
presented as mean ± standard deviation, whereas the 
data without normal distribution were introduced as 
median with minimum-maximum levels. The mann 
whitney u, one way AnOvA, independent samples 
test, Student’s t-test and χ2-test were used to compare 
data groups. The level of statistical significance was set 
at p<0.05.
Results
A total of 218 patients were enrolled in this study. 
The main evaluation was initiated by dividing the 
group into H. pylori positive and H. pylori negative pa-
tients. There were 118 (54.2%) H. pylori positive and 
100 (45.8%) H. pylori negative patients. Age, gender, 
hemoglobin, mean corpuscular volume, ferritin, CrP, 
serum iron, endoscopic findings, and platelet count 
were similar in both groups (p>0.05 all) (table 1). The 
mPv and platelet count did not differ between H. py-
lori positive and H. pylori negative groups (p>0.05). 
There was no difference in the mean mPv levels be-
tween the subgroups of inflammation according to 
Sydney classification (p>0.05 all). There was no corre-
lation between the mean mPv levels and the severity 
of inflammation either (table 2). when evaluating the 
mean mPv as <9.15 fl and >9.15 fl with gender 
matching (according to the study by Icli et al.12), there 
were no differences between H. pylori positive and H. 
pylori negative groups either (p>0.05 all) (table 3).
Discussion
In this study, we evaluated the relationship between 
the mean mPv and chronic gastric inflammation se-
verity, with H. pylori positive and negative. Our main 
findings showed that the mean mPv was not different 
between H. pylori positive and H. pylori negative 
groups (p>0.05), and no statistical correlation and dif-
ferences were found among the gastric inflammation 
subgroups, or in the severity of inflammation accord-
ing to Sydney classification. we analyzed mPv mea-
surement by stratifying <9.15 fl and >9.15 fl groups, 





Patients (n, %) 118 (54.2%) 100 (45.8%) 0.799
Age (yrs) 52.8±13.6 52.3±15.5 0.724
gender (male/female) 64/54 55/45 0.910
Platelet x106 µ/ml (nr: 140-400) 250±58.8 243±49.7 0.724
mPv (fl) (nr:7-10.5) 8.67±1.02 8.68±0,81 0.998
hemoglobin (mg/dl) (nr: 12-16.5) 14.1±1.23 14.2±1.15 0.495
mCv (fl) (nr:80-99) 87.2±3.31 87.7±3.79 0.330
ferritin (mg/dl) (nr:11-308.6) 46.2(9.5-253) 43.2(11-323) 0.903
Serum iron (µg/dL) (nr: 60-180) 77±27.9 76,62±30.07 0.923
CrP (mg/dl) (nr: 0-8) 2.54±1.46 3.06±1.12 0.854
endoscopic findings:
eSg
lower esophageal sphincter dysfunction + eSg








H. pylori = Helicobacter pylori; nr = normal range; nS = nonsignificant; mPv = mean platelet volume; mCv = mean corpuscular volume; 
CrP = C-reactive protein; eSg = erythematous superficial gastritis; mPv was not different between H. pylori positive and H. pylori nega-
tive groups (p>0.05).
T. Akar Mean platelet volume and Helicobacter pylori
Acta Clin Croat, Vol. 58, No. 4, 2019 579
but we found no differences between H. pylori positive 
and H. pylori negative groups. The most powerful parts 
of our work were as follows: we analyzed all patient 
files very carefully and selected the cases among special 
patient groups who had no serious chronic disease ex-
cept for dyspepsia, and therefore we kept such patients 
out of the study if it was the smallest factor that could 
affect the results such as a drug, chronic inflammatory 
disease, etc.; unlike previous studies, we measured 
CrP levels in all patients to exclude any acute or 
chronic inflammation that could affect platelet func-
tion. Therefore, even a patient with the smallest CrP 
elevation was not included in the study; and all endo-
scopic procedures and histologic examinations were 
done by the same clinicians having at least ten years of 
experience in the field. So, the diagnosis of H. pylori 
and gastric inflammation scores were very reliable. The 
most important limitation of our work was its retro-
spective design.
Our results were similar to the study by topal et al.9, 
but different from the study by umit and Ümit16. In the 
former involving 114 patients, there was no correlation 
or difference between the mean mPv and H. pylori 
presence, as well as gastric inflammation severity 
(p>0.05). Our study had a higher number of patients 
than the study by topal et al.9 (218 vs. 114), so our re-
sults could be more reliable than those reported by these 
authors. moreover, they did not consider all factors that 
might affect mPv and platelet function in their study; 
unlike them, we did take in consideration important pa-
rameters such as CrP and iron storage status. The study 
by umit and Ümit16 that included 4823 patients found 
the mean mPv and platelet count to be statistically dif-
ferent between H. pylori positive and H. pylori negative 
groups (p<0.001). They also report that 20.5% of H. py-
lori positive patients had a higher mPv value (>10 fl), 
while 2.8% of H. pylori negative patients had high mPv 
(>10 fl), and this finding was statistically significant 
(p<0.001). These results are completely different from 
the results of our study and the study by topal et al.9. 
Therefore, we considered this result as conflicting and 
table 2. Mean platelet volume (MPV) values were  
not different among inflammation groups, so there was  
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table 3. MPV evaluation as <9.15 fl and >9.15 fl with gender-matched subjects (according to the study by  





















13 (35.1%) 0.153H. pylori (-)
total (218%100) 72 (100%) 27 (100%) 82 (100%) 37 (100%)
H. pylori = Helicobacter pylori; mPv = mean platelet volume; fl = femtolitre
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discordant information due to some reasons. In their 
study, umit and Ümit16 included 4823 patients who had 
undergone upper endoscopy, but no endoscopic findings 
are reported. According to that study, it is doubtful how 
the H. pylori diagnosis was obtained. Another problem 
associated with that study was that it was carried out 
between 2004 and 2014 (ten years), so this long working 
time could have caused data loss or changes, thus the 
data could not be homogeneous. Consequently, we did 
not find the results reported by umit and Ümit16 as reli-
able. In table 4, we summarized the studies of mPv 
and H. pylori presence, as well as gastric inflammation 
severity.
The mPv has recently become a favorite topic of 
many researchers as a simple, easy-going and inexpen-
sive marker of chronic inflammation-related diseas-
es14,17,18. In many studies involving systemic diseases 
such as diabetes mellitus or Behçet disease, the mean 
mPv was statistically different between patient group 
and control group19,20. however, this difference was not 
shown in localized inflammatory diseases such as 
graves’ disease or rheumatoid arthritis13,15.
up to now, H. pylori is still a hot topic, and it con-
tinues to be the subject of many studies. nowadays, 
mPv has been presented as a new, promising and 
straightforward marker of inflammation. however, 
there are only a few studies demonstrating a relation-
ship between mPv and H. pylori. Conflicting results 
have been presented so far. These studies are briefly 
summarized in table 4 with essential demographic 
data and results/conclusions. Our study is the fourth 
paper evaluating mPv and gastric inflammation se-
verity, being H. pylori positive or negative. Our work 
contributes to the literature by clarifying this issue, 
which has a small number of contradictory informa-
tion, as clearly seen in the literature summary. to us, 
when the inflammation is located at a highly limited 
site such stomach and anterior part of the eye, there is 
not enough cytokine and immunomodulator release, 
thus platelet activation from bone marrow is not so 
prominent to activate mPv8.
In conclusion, although mPv has recently emerged 
as a marker of inflammation in many systemic diseases, 
there is still an ongoing debate about its diagnostic 
usefulness and benefit in daily clinical practice. This 
paper is the fourth study to investigate the relationship 
between mPv and H. pylori related chronic gastric in-
flammation severity. Our results show that mPv is not 
a useful marker of chronic gastric inflammation sever-
ity, being H. pylori positive or negative.
table 4. Summary of studies investigating the relationship between MPV and H. pylori related gastric inflammation 
severity




(mean) Plt p result/Conclusion
topal et al. 114
(73/41
2010 38.5±13.12 8.8±1.4 - >0.05 mPv level cannot be used as a 
simple marker to reflect H. pylori 






2015 60(18-80) 8.79±1 247±82 <0.001 higher mPv values were observed 
in H. pylori positive patients
güçlü et al.21 199
(111/88)
2017 46.5±14 10.1±0.7 270±79 >0.05 There were no differences between 
mPv and total H. pylori-negative 







2018 52.8±13.6 8.67±1.02 250 ±58 >0.05 There were no differences in mean 
mPv between H. pylori positive 
and negative patients or among 
chronic gastric inflammation 
subgroups
H. pylori = Helicobacter pylori; mPv = mean platelet volume; fl = femtolitre; Plt = platelet; f = female; m = male
topal et al.9 found that there was no relationship between mean mPv and chronic gastric inflammation severity being H. pylori positive or 
negative, whereas umit and Ümit16 claimed that higher mPv values were observed in H. pylori positive patients
T. Akar Mean platelet volume and Helicobacter pylori
Acta Clin Croat, Vol. 58, No. 4, 2019 581
References
1. díaz P, valenzuela valderrama m, Bravo J, Quest Afg. Heli-
cobacter pylori and gastric cancer: adaptive cellular mechanisms 
involved in disease progression. front microbiol. 2018;9:5.
2. dutta AK, reddy vd, Iyer vh, unnikrishnan lS, Chacko A. 
exploring current status of Helicobacter pylori infection in dif-
ferent age groups of patients with dyspepsia. Indian J gastro-
enterol. 2017 nov;36(6):509-513. doi: 10.1007/s12664-017-
0810-0. epub 2018 Jan 24.
3. muhammad JS, Zaidi Sf, Saeed SA, Ishaq m. Current status of 
Helicobacter pylori association with haematological and cardio-
vascular diseases: a mini review. J Pak med Assoc. 
2017;67(6):907-11.
4. yun Zy, li n, Zhang X, et al. mean platelet volume, platelet 
distribution width and carcinoembryonic antigen to discrimi-
nate gastric cancer from gastric ulcer. Oncotarget. 
2017;8(37):62600-5.
5. Shichijo S, nomura S, Aoyama K, et al. Application of convo-
lutional neural networks in the diagnosis of Helicobacter pylori 
infection based on endoscopic images. eBiomedicine. 
2017;25:106-11.
6. moayyedi Pm, lacy Be, Andrews Cn, enns rA, howden 
Cw, vakil n. ACg and CAg Clinical guideline: manage-
ment of dyspepsia. Am J gastroenterol. 2017;112(7):988-
1013.
7. Shetty v, Ballal m, Balaraju g, Shetty S, Pai gC, lingadakai 
r. Helicobacter pylori in dyspepsia: phenotypic and genotypic 
methods of diagnosis. J glob Infect dis. 2017;9(4):131-4.
8. noris P, melazzini f, Balduini Cl. new roles for mean platelet 
volume measurement in the clinical practice? Platelets. 
2016;27(7):607-12.
9. topal f, Karaman K, Akbulut S, et al. The relationship between 
mean platelet volume levels and the inflammation in Helico-
bacter pylori gastritis. J natl med Assoc. 2010;102(8):726-30.
10. Bahali Ag, Su O, emiroglu n, Cengiz fP, Kaya mO, Onsun 
n. evaluation of mean platelet volume in localized scleroder-
ma. An Bras dermatol. 2017;92(5):635-7.
11. Kılıç S, reşorlu h, Işik S, et al. Association between mean 
platelet volume and disease severity in patients with psoriasis 
and psoriatic arthritis. Postepy dermatol Alergol. 
2017;34(2):126-30.
12. Icli A, Aksoy f, turker y, et al. relationship between mean 
platelet volume and pulmonary embolism in patients with deep 
vein thrombosis. heart lung Circ. 2015;24(11):1081-6.
13. Bagir gS, haydardedeoglu fe, Bakiner OS, Bozkirli e, er-
torer me. mean platelet volume in graves’ disease: a sign of 
hypermetabolism rather than autoimmunity? Pak J med Sci. 
2017;33(4):871-5.
14. Avci A, Avci d, erden f, et al. Can we use the neutrophil-to-
lymphocyte ratio, platelet-to-lymphocyte ratio, and mean 
platelet volume values for the diagnosis of anterior uveitis in 
patients with Behcet’s disease? Ther Clin risk manag. 
2017;13:881-6.
15. moghimi J, ghahremanfard f, Salari m, ghorbani r. Associa-
tion between mean platelet volume and severity of rheumatoid 
arthritis. Pan Afr med J. 2017;27:276.
16. umit h, Ümit eg. Helicobacter pylori and mean platelet vol-
ume: a relation way before immune thrombocytopenia? eur 
rev med Pharmacol Sci. 2015;19(15):2818-23.
17. Chen X, fang l, lin h, et al. The relationship between type 2 
diabetes and platelet indicators. Iran J Public health. 
2017;46(9):1211-6.
18. lei JJ, Zhou l, liu Q, Xiong C, Xu Cf. Can mean platelet 
volume play a role in evaluating the severity of acute pancreati-
tis? world J gastroenterol. 2017;23(13):2404-13.
19. yayla Abide Ç, vural f, Kılıççı Ç, et al. Can we predict severity 
of intrahepatic cholestasis of pregnancy using inflammatory 
markers? turk J Obstet gynecol. 2017;14(3):160-5.
20. uslu Au, Aydin B, Balta S, yonem O, uncu t, Seven d. The 
effect of standard therapy on mean platelet volume in patients 
with chronic hepatitis C. Prz gastroenterol. 2016;11(3):200-5.
21. guclu m, Agan f. Association of severity of Helicobacter pylori 
infection with peripheral blood neutrophil to lymphocyte ratio 
and mean platelet volume. euroasian J hepatogastroenterol. 
2017 Jan-Jun;7(1):11-6.
T. Akar Mean platelet volume and Helicobacter pylori
582 Acta Clin Croat, Vol. 58, No. 4, 2019
Sažetak
mOŽe lI vOlumen trOmBOCItA uKAZIvAtI  
nA POZItIvAn StAtuS nA HelIcobacter I teŽInu uPAle ŽeluCA?  
IZvOrnO IStrAŽIvAnJe I Pregled lIterAture
t. akar
Helicobacter pylori (H. pylori) je čest problem i značajan uzrok kronične upale želuca. H. pylori, trajna upala želuca i njezi-
na težina su najkritičnija komponenta prekursora raka želuca. hipotetski, svaka kronična ozljeda tkiva aktivira trombocite, a 
srednji volumen trombocita (mean platelet volume, mPv) dobro odražava njihovo djelovanje. Potencijalni odnos između H. 
pylori i broja trombocita je prikazan ranije. međutim, postoji i nekoliko suprotnih članaka o odnosu između mPv i kroničnih 
upala želuca povezanih s H. pylori i njihove težine. Istraživanje je imalo za cilj procjenjivati  bilo koji potencijalni odnos izme-
đu mPv i postojanja H. pylori, kao i težine kronične upale želuca. u početku je evaluirano 6890 endoskopskih izvješća, a 
uključeno je ukupno 218 dispeptičnih bolesnika koji su podvrgnuti gornjoj endoskopiji. Od njih je 118 (54,2%) bolesnika 
bilo pozitivno na H. pylori, dok ih je 100 (45,8%) bilo negativno na H. pylori. najmanje četiri želučane biopsije su uzete i 
ocjenjivane prema klasifikaciji Sydney. Zabilježeni su i dob, spol, hemoglobin, srednji korpuskularni volumen, feritin, serum-
sko željezo i C-reaktivni protein te endoskopski nalazi. vrijednost p<0,05 je prihvaćena kao značajna. mPv i broj trombo-
cita nisu se razlikovali između skupina bolesnika pozitivnih i negativnih na H. pylori (p>0,05). također nije bilo razlike i 
korelacije između mPv i težine upale želuca prema klasifikaciji Sydney (p>0,05). Kada je mPv stratificiran kao <9,15 fl i 
>9,15 fl, također nije nađena nikakva razlika između skupina bolesnika pozitivnih i negativnih na H. pylori (p>0,05). u ovom 
istraživanju nismo pronašli nikakav odnos između mPv i postojanja H. pylori, kao i težine upale želuca. Iako u ovom pogle-
du još postoje sukobljene publikacije, za nas i ovu studiju mPv nije prikladan biljeg za procjenu jačine želučanih upala, bez 
obzira je li H. pylori pozitivan ili negativan.
Ključne riječi: Srednji volumen trombocita; Helicobacter pylori; Gastritis; Upala
